Partners Innovation Fund, LLC 4
4 · Akouos, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Akouos, Inc.AKUS
Partners Innovation Fund, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-06-30+342,505→ 445,256 total - Conversion
Common Stock
2020-06-30+102,751→ 102,751 total - Conversion
Common Stock
2020-06-30+119,997→ 565,253 total - Conversion
Series A Preferred Stock
2020-06-30−342,505→ 0 total→ Common Stock (342,505 underlying) - Conversion
Series Seed Preferred Stock
2020-06-30−102,751→ 0 total→ Common Stock (102,751 underlying) - Conversion
Series B Preferred Stock
2020-06-30−119,997→ 0 total→ Common Stock (119,997 underlying)
Footnotes (4)
- [F1]On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]The securities are held by Partners Innovation Fund, LLC ("PIF"). PIF is a limited liability company controlled by its members. The Members of PIF are (1) The General Hospital Corporation (commonly referred to as "MGH"), (2) Brigham and Women's Hospital and (3) Massachusetts Eye and Ear.
- [F3]On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F4]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.